(Q34799624)

4 August 2017

1 reference

title

Helicobacter pylori infection in geriatrics (English)

1 reference

Helicobacter pylori infectious disease

4 August 2017

0 references

1 reference

Alberto Pilotto

1

1 reference

4 August 2017

Nathalie Salles

series ordinal

2

1 reference

4 August 2017

publication date

1 January 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

7 Suppl 1

1 reference

4 August 2017

page(s)

56-62

1 reference

The quality of care for Medicare patients with peptic ulcer disease

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Helicobacter pylori and gut hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Helicobacter pylori eradication attenuates oxidative stress in human gastric mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Cardiovascular risk factors in subjects with Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Effect of Helicobacter pylori infection and its eradication on nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Eradication of Helicobacter pylori infection induces an increase in body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

How to determine the diagnosis of Helicobacter pylori infection in the elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Review article: an approach to Helicobacter pylori infection in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Treatment of Helicobacter pylori infection in elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Relevance of underlying disease and bacterial vacA and cagA status on the efficacy of Helicobacter pylori eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. pylori infection: a multiple logistic regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Review article: treatment of Helicobacter pylori infection and factors influencing eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

Management of Helicobacter pylori eradication--the influence of structured counselling and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.7.S1.9.X

10.1046/J.1523-5378.7.S1.9.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference